Codexis, Inc.

Codexis, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Codexis, Inc. is not a good value stock. Codexis, Inc. is not very popular among insiders. Codexis, Inc. is a mediocre stock to choose.
Log in to see more information.
Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme...

News

Codexis Announces New Employment Inducement Grants
Codexis Announces New Employment Inducement Grants

Globe Newswire REDWOOD CITY, Calif., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced the approval of equity grants to three new employees as...\n more…

Codexis to Participate in Upcoming Healthcare Conferences
Codexis to Participate in Upcoming Healthcare Conferences

Globe Newswire REDWOOD CITY, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that management will participate in two upcoming...\n more…

Cantor Fitzgerald Reiterates Overweight Rating for Codexis (NASDAQ:CDXS)
Cantor Fitzgerald Reiterates Overweight Rating for Codexis (NASDAQ:CDXS)

Zolmax Codexis (NASDAQ:CDXS - Get Free Report)s stock had its "overweight" rating reissued by stock analysts at Cantor Fitzgerald in a research note issued on Thursday, Benzinga reports. They...\n more…

Cantor Fitzgerald Reiterates Overweight Rating for Codexis (NASDAQ:CDXS)
Cantor Fitzgerald Reiterates Overweight Rating for Codexis (NASDAQ:CDXS)

Ticker Report Codexis (NASDAQ:CDXS - Get Free Report)s stock had its "overweight" rating reissued by stock analysts at Cantor Fitzgerald in a research note issued on Thursday, Benzinga reports. They...\n more…

Codexis, Inc. (NASDAQ:CDXS) Shares Acquired by SG Americas Securities LLC
Codexis, Inc. (NASDAQ:CDXS) Shares Acquired by SG Americas Securities LLC

Ticker Report SG Americas Securities LLC increased its position in Codexis, Inc. (NASDAQ:CDXS - Free Report) by 72.6% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange...\n more…

Cantor Fitzgerald Weighs in on Codexis, Inc.'s FY2024 Earnings (NASDAQ:CDXS)
Cantor Fitzgerald Weighs in on Codexis, Inc.'s FY2024 Earnings (NASDAQ:CDXS)

Ticker Report Codexis, Inc. (NASDAQ:CDXS - Free Report) - Cantor Fitzgerald reduced their FY2024 earnings per share estimates for Codexis in a note issued to investors on Thursday, August 22nd. Cantor Fitzgerald...\n more…